ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age (SORAML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00893373
Recruitment Status : Completed
First Posted : May 6, 2009
Last Update Posted : February 5, 2016
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Technische Universität Dresden

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : September 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):